| ATC-group (2nd level) | Prescriptions/sales | ||
|---|---|---|---|
| Prescriptions in millions   | Net costs in million € Info | Number | |
| A01 Stomalogical preparations | 1.9 | 24.9 | 427.1 |
| A02 Ulcer therapeutics | 32.1 | 578.0 | 3,839.0 |
| A03 Spasmolytics | 3.0 | 44.7 | 41.9 |
| A04 Antiemetics and agents for sickness | 2.0 | 86.5 | 10.7 |
| A05 Bilious and liver therapy | 0.7 | 90.4 | 32.6 |
| A06 Laxatives | 4.1 | 115.4 | 105.2 |
| A07 Antidiarrheals | 3.2 | 264.7 | 116.0 |
| A10 Antidiabetics | 35.2 | 3,605.5 | 2,717.2 |
| A11 Vitamins | 5.3 | 92.7 | 689.1 |
| A12 Minerals | 2.1 | 42.5 | 91.1 |
| B01 Antithrombotical agents | 25.5 | 3,221.5 | 2,007.5 |
| B03 Antianemic combinations | 5.1 | 435.6 | 339.0 |
| B05 Blood substitute drugs and perfusion solutions | 2.8 | 377.0 | 32.6 |
| C01 Cardiac therapeutics | 5.7 | 244.4 | 307.7 |
| C02 Antihypertensives | 5.6 | 308.1 | 391.9 |
| C03 Diuretics | 25.2 | 524.1 | 1,894.7 |
| C05 Vasoprotectives | 0.7 | 14.9 | 11.8 |
| C08 Calcium antagonists | 24.2 | 305.0 | 2,705.5 |
| C09 Angiotensin inhibitor | 67.9 | 1,838.3 | 10,876.0 |
| C10 Antilipemics | 31.3 | 840.9 | 3,652.2 |
| D01 Antifungals (topical) | 4.3 | 102.2 | 87.8 |
| D04 Antipruriginous agents | 0.4 | 4.4 | 11.4 |
| D05 Antipsoriatics | 0.9 | 91.3 | 62.4 |
| D06 Antiinfectives (dermatological) | 2.2 | 51.4 | 30.7 |
| D07 Corticosteroids (dermatological) | 10.1 | 181.6 | 369.0 |
| D10 Anti-acne preparations | 1.7 | 46.8 | 51.0 |
| D11 Other dermatological preparations | 2.3 | 527.5 | 90.2 |
| G01 Gynaecological antiinfectivs | 0.6 | 9.3 | 2.8 |
| G03 Sexual hormones | 10.6 | 369.3 | 1,089.4 |
| G04 Urological drugs | 9.1 | 345.7 | 798.9 |
| H02 Corticosteroids (systemic) | 9.5 | 189.8 | 444.5 |
| H03 Thyroids therapeutics | 30.3 | 422.5 | 1,906.3 |
| J01 Antibiotics | 30.2 | 605.7 | 269.7 |
| J05 Antivirals | 1.9 | 1,139.0 | 60.2 |
| J07 Vaccines | 0.7 | 56.9 | 0.7 |
| L01 Antineoplastic agents | 5.9 | 8,535.6 | 91.4 |
| L02 Hormone antagonists | 2.2 | 1,432.2 | 174.4 |
| L03 Immunostimulants | 0.5 | 874.4 | 18.2 |
| L04 Immunosuppressants | 4.1 | 7,991.6 | 235.4 |
| M01 Antiphlogistics/anti-inflammatory drugs | 40.0 | 635.6 | 1,119.9 |
| M03 Muscle relaxants | 3.8 | 239.8 | 198.0 |
| M04 Gout agents | 7.1 | 102.7 | 362.3 |
| M05 Osteoporosis agents | 2.7 | 470.6 | 231.9 |
| N02 Analgesics | 63.6 | 2,153.8 | 965.3 |
| N03 Antiepileptics | 6.7 | 512.6 | 324.4 |
| N04 Anti parkinson drugs | 6.4 | 447.3 | 158.5 |
| N05 Psycholeptics | 23.1 | 873.6 | 561.5 |
| N06 Psychoanaleptics | 27.8 | 920.6 | 2,004.2 |
| N07 Anti vertiginous and addiction therapeutics | 5.5 | 576.9 | 195.8 |
| R01 Rhinologic drugs | 10.9 | 91.0 | 299.5 |
| R03 Anti-asthma medication | 27.2 | 2,210.4 | 1,456.1 |
| R05 Cough and cold preparations | 9.3 | 105.7 | 88.2 |
| R06 Antihistamines | 2.8 | 53.6 | 126.3 |
| S01 Ophthalmic drugs | 44.0 | 613.8 | 2,117.6 |
| S02 Otologicals | 1.5 | 25.2 | 17.7 |
| V01 Allergenes | 0.9 | 450.9 | 166.4 |
| V03 Antidotes/other agents | 0.8 | 148.0 | 17.3 |
| N01 Anesthetics | 0.3 | 18.7 | 3.2 |
| M09 Other agents for disorders of muscle and skeleton system | 0.5 | 235.7 | 26.6 |
| P02 Anthelmintics | 0.9 | 39.8 | 2.0 |
| B02 Antihemorrhagics | 0.7 | 1,033.4 | 4.5 |
| J02 Antifungals | 0.6 | 79.4 | 5.7 |
| D08 Antiseptics and disinfective agents | 0.6 | 6.7 | 8.8 |
| R04 Chest ointment and other inhalants | 0.7 | 10.7 | 12.0 |
| H05 Calcium homoeostasis | 0.4 | 145.6 | 10.8 |
| A09 Digestives, including enzymes | 1.2 | 91.1 | 23.3 |
| D09 Medical bandages | 0.6 | 83.8 | 18.0 |
| D02 Agents for skin protection | 0.9 | 28.8 | 33.3 |
| G02 Other gynecologicals | 0.3 | 13.9 | 17.8 |
| H01 Pituitary/hypothalamic hormones | 0.4 | 424.8 | 16.7 |
| J06 Immune sera and immunoglobulins | 0.4 | 725.6 | 6.0 |
| P03 Insecticides and repellents | 0.7 | 24.2 | 1.7 |
| P01 Agents againt protozoa | 0.8 | 18.0 | 11.0 |
| S03 Ophthalmic drugs/otologicals | 19.2 | 1,625.2 | 871.0 |
| R02 Throat and pharynx therapeutics | 0.4 | 3.1 | - |
| D03 Wound treatment agents | 0.3 | 4.3 | 7.4 |
(See also more information on Source(s)/Contact, Comment(s), Links, Refresh period of data) To the interactive graphics
Show value selection
(On the page "Value selection" you can choose for every dimension any dimension value for your selection.)Interactive graphics 
Line chart
Line chart - German Drug Index, AOK Research Institute (WIdO) (more information on Popup, more information onPopup)
- PopupPopup
- Reported are pharmaceutical groups with a percentage of prescriptions or a percentage of sales of at least 0.1 percent of the overall market.
- The table was extended by the year 2022 on 11 Apr 2024.
Information for a new reporting period will be added as soon as it is available.
- Information concerning Pharmaceuticals according to the Red List .
The Federal Health Monitoring System 20. Apr 2024